Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
27,86 USD | -3,93 % | +2,99 % | -30,99 % |
Resumen de negocios
Número de empleados: 553
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Transformative Medicines
100,0
%
| 78 | 100,0 % | 9 | 100,0 % | -88,02 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 78 | 100,0 % | 9 | 100,0 % | -88,02 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 01/01/15 |
Charles Homcy
FOU | Founder | 75 | 01/01/15 |
Founder | 73 | 01/01/15 | |
Brian Stephenson
DFI | Director of Finance/CFO | 43 | 01/10/18 |
Jonathan Fox
PSD | President | 66 | - |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/04/16 |
Christine Siu
COO | Chief Operating Officer | 47 | 01/01/20 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Vikram Bali
IRC | Investor Relations Contact | - | - |
Adora Ndu
LAW | General Counsel | 43 | 01/01/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 01/03/16 |
Founder | 73 | 01/01/15 | |
Fred Hassan
BRD | Director/Board Member | 78 | 17/08/21 |
Charles Homcy
FOU | Founder | 75 | 01/01/15 |
Randal Scott
BRD | Director/Board Member | 66 | 23/06/20 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Douglas Dachille
BRD | Director/Board Member | 59 | 17/08/21 |
Ali Satvat
BRD | Director/Board Member | 46 | 01/03/16 |
Andrew Lo
FOU | Founder | 63 | 01/01/15 |
Neil Kumar
FOU | Founder | 45 | 01/01/15 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 193 321 021 | 144 854 156 ( 74,93 %) | 6 191 761 ( 3,203 %) | 74,93 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
LIANBIO 4.75% | 5 002 792 | 4.75% | 1 643 667 $ |
Información de la empresa
BridgeBio Pharma, Inc.
3160 Porter Drive Suite 250
94304, Palo Alto
+650 391 9740
http://www.bridgebio.comVentas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-30,99 % | 5213,42 M | |
+0,85 % | 92,38 mil M | |
-3,03 % | 37,9 mil M | |
-10,46 % | 33,73 mil M | |
+74,71 % | 27,98 mil M | |
-13,39 % | 15,86 mil M | |
-1,08 % | 13,97 mil M | |
-11,15 % | 11,67 mil M | |
+169,04 % | 10,17 mil M | |
-50,19 % | 10,04 mil M |
- Bolsa de valores
- Acciones
- Acción BBIO
- Empresa BridgeBio Pharma, Inc.